Abstract
Esophageal cancer (EC) is a malignant tumor with high mortality. This study aimed to identify the optimal examined lymph node (ELN) count threshold and develop a model to predict survival after radical esophagectomy. Analyzing a training cohort (n=734, Chinese registry) and an external testing cohort (n=3208, SEER registry), we found that a higher ELN count significantly correlates with improved survival. The optimal cut-off was determined to be 18 nodes. A Random Survival Forest (RSF) model was developed, demonstrating high predictive accuracy (AUC: 87.5 in training, 79.3 in testing) and low Brier Scores. These findings suggest that an ELN count exceeding 18 is a critical prognostic factor and that the RSF model provides a robust tool for individual risk assessment.
Introduction
Esophageal cancer (EC) remains one of the most aggressive malignancies globally, ranking sixth in cancer-related mortality. While radical esophagectomy is the cornerstone of treatment, predicting long-term survival is challenging. The traditional TNM (Tumor-Node-Metastasis) staging system often fails to account for the significant variability in outcomes among patients within the same stage.
A critical surgical consideration is the extent of lymphadenectomy. The number of examined lymph nodes (ELN) is vital for accurate staging; however, the "optimal" number remains a subject of debate. Insufficient dissection leads to "under-staging" (stage migration), while excessive dissection may increase surgical morbidity. This study sought to define a definitive ELN threshold and leverage machine learning to improve prognostic accuracy.
Methods
The study utilized two large-scale datasets: a training cohort of 734 patients from the Affiliated Cancer Hospital of Zhengzhou University and an external validation cohort of 3,208 patients from the U.S. SEER registry.
To move beyond the limitations of linear statistical models, researchers employed:
- Lasso-Cox Regression: Used for variable selection to identify clinical factors (e.g., age, sex, tumor site) with the most significant impact on survival.
- Random Survival Forest (RSF): An ensemble machine learning algorithm that builds multiple decision trees to capture complex, non-linear interactions between variables.
- Performance Metrics: Model discrimination was evaluated using the C-index and Area Under the Curve (AUC), while prediction error was assessed via the Brier Score.
Results
The Prognostic Significance of the 18-Node Threshold
Statistical analysis identified 18 as the optimal ELN count threshold. In both the training and testing cohorts, patients with more than 18 ELNs demonstrated significantly better overall survival (OS) and disease-free survival (DFS).
The Hazard Ratio (HR) for ELN count was 0.98 (P < 0.01) in both cohorts, indicating that each additional node examined slightly reduces the risk of mortality. This suggests that thorough lymphadenectomy may offer a direct therapeutic benefit by removing occult micrometastases.
Machine Learning Model Performance
The RSF model consistently outperformed traditional TNM-based and Lasso-Cox models. In the training cohort, the RSF model achieved an AUC of 87.5, while in the external SEER testing cohort, it maintained a robust AUC of 79.3.
Furthermore, the RSF model exhibited the lowest Brier Scores (0.122 in training, 0.152 in testing), confirming its reliability and superior predictive power compared to conventional methods.
Discussion
The identification of 18 ELNs as a critical threshold provides a clear target for surgeons to ensure adequate staging and potentially improve patient outcomes. By reducing "stage migration"—where metastatic nodes are missed—this threshold ensures patients receive appropriate adjuvant therapies.
The success of the RSF model highlights the potential of machine learning in oncology. Unlike traditional formulas, RSF handles the "messy" nature of biological data more effectively. However, limitations remain, including the retrospective nature of the data and the "black box" aspect of machine learning, which can make clinical interpretation difficult. Future work should focus on integrating genomic and inflammatory biomarkers into these models to further refine personalized prognosis.
Conclusion
An ELN count of at least 18 is significantly associated with improved survival in esophageal cancer patients following radical esophagectomy. The developed RSF model offers a high-accuracy tool for individual prognosis, outperforming traditional staging systems and providing a foundation for more personalized clinical decision-making.
Summary updated